Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CDA Antibody (R3J38)

Catalog #:   RHE00202 Specific References (46) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, IP, WB
Accession: P32320
Overview

Catalog No.

RHE00202

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:50-1:250, IP: 1:100-1:200, WB: 1:500-1:1000

Target

Cytidine deaminase, CDD, Cytidine aminohydrolase, CDA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P32320

Applications

IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3J38

Data Image
  • Immunohistochemical
    IHC-P analysis of spleen tissue by CDA antibody (RHE00202). IHC-P was performed using sections of the formalin-fixed paraffin-embedded spleen tissue;Result: Cells in red pulp are positively stained.
  • Immunoprecipitation
    Lane 1: SK-OV-3 lysate; Lane 2: CDA immunoprecipitated from SK-OV-3 lysate by RHE00202;Lane 3: The same as Lane 2 but use IgG isotype control antibody;Result: RHE00202 can immunoprecipitate CDA;
  • Western blot
    Western blot analysis using CDA mouse mAb against HeLa lysate and 30 µg SK-OV-3 lysate
References

A case-cohort longitudinal study for the analysis of microbial associations and viruses on the risk of celiac disease (MAVRiC)., PMID:40492061

Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023., PMID:40342248

Non-Invasive Monitoring and Differentiation of Aging Mice Treated with Goat Whey Powder by an Electronic Nose Coupled with Chemometric Methods., PMID:40096321

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes., PMID:40090995

Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue., PMID:40090994

A conformational fingerprint for amyloidogenic light chains., PMID:40028903

Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study., PMID:40025641

Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measures., PMID:39961655

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients., PMID:39959979

Eastern cottontails (Sylvilagus floridanus) as hosts for ticks infected with Borrelia burgdorferi, Anaplasma phagocytophilum, and Powassan virus in Virginia, USA., PMID:39945387

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review., PMID:39830356

Infliximab monitoring in Crohn's disease: a neural network approach for evaluating disease activity and immunogenicity., PMID:39664232

Hairy cell leukemia (HCL) and HCL-like disorders: present, emergent treatment options and future directions., PMID:39535173

Detection of host cell microprotein impurities in antibody drug products., PMID:39366928

Study of Number of Germinal Centers of Vermiform Appendix in Bangladeshi People of Different Age and Sex., PMID:39351749

M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge., PMID:39237609

The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence., PMID:39236459

A whole-cell platform for discovering synthetic cell adhesion molecules in bacteria., PMID:39095377

Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia., PMID:39052709

A quadrivalent recombinant influenza Hemagglutinin vaccine induced strong protective immune responses in animal models., PMID:38834431

Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores., PMID:38797187

Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry., PMID:38761203

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma., PMID:38709066

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity., PMID:38459086

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma., PMID:38448430

Protein and lipid expansion microscopy with trypsin and tyramide signal amplification for 3D imaging., PMID:38081848

Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children., PMID:38068757

Associations of dietary patterns between age 9 and 24 months with risk of celiac disease autoimmunity and celiac disease among children at increased risk., PMID:38044022

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study., PMID:37783133

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign., PMID:37766374

TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells., PMID:37533642

Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis., PMID:37495267

Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal., PMID:37389189

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial., PMID:37371853

Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations., PMID:37212741

Lymph Node Follicle-Targeting STING Agonist Nanoshells Enable Single-Shot M2e Vaccination for Broad and Durable Influenza Protection., PMID:37092580

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective., PMID:37074241

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial., PMID:37052965

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD., PMID:36809847

Long-term follow-up of patients with hairy cell leukemia in the south of Iran., PMID:36709461

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients., PMID:36700064

In-depth immunophenotyping reveals significant alteration of lymphocytes in buffalo with brucellosis., PMID:36602043

IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation., PMID:36559314

Reply to Ito., PMID:36533701

Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme., PMID:36440540

Systematic review: early feeding practices and the risk of coeliac disease. A 2022 update and revision., PMID:36411726

Datasheet

Document Download

Anti-CDA Antibody (R3J38).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CDA Antibody (R3J38) [RHE00202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only